fluorodopa f 18 has been researched along with Cortical Lewy Body Disease in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baudrexel, S; Diederich, NJ; Eggers, C; Heiss, WD; Hilker, R; Hohmann, C; Kalbe, E; Klein, JC; Vollmar, S; Weisenbach, S | 1 |
Benlloc, L; Cuello, D; Fragoso, M; Salazar, G | 1 |
Goldstein, DS; Holmes, C; Park, MY; Sewell, L; Sharabi, Y | 1 |
Arai, H; Higuchi, M; Hu, XS; Ido, T; Itoh, M; Matsui, T; Okamura, N; Sasaki, H; Shinkawa, M; Tashiro, M | 1 |
Hisanaga, K; Iwasaki, Y; Jin, K; Mochizuki, H; Sato, N; Suzuki, H; Tanji, H | 1 |
5 other study(ies) available for fluorodopa f 18 and Cortical Lewy Body Disease
Article | Year |
---|---|
Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo.
Topics: Acetylcholine; Aged; Brain; Brain Mapping; Dihydroxyphenylalanine; Dopamine; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Lewy Bodies; Lewy Body Disease; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography | 2010 |
Neuropsychiatric symptoms in Lewy body diffuse disease: a case report.
Topics: Aged; Antidepressive Agents; Cognition Disorders; Depressive Disorder, Major; Dihydroxyphenylalanine; Hallucinations; Humans; Lewy Body Disease; Male; Neuropsychological Tests | 2011 |
Sympathetic noradrenergic before striatal dopaminergic denervation: relevance to Braak staging of synucleinopathy.
Topics: Aged; alpha-Synuclein; Autonomic Denervation; Dementia; Dihydroxyphenylalanine; Disease Progression; Dopamine; Dopaminergic Neurons; Gait Disorders, Neurologic; Hallucinations; Humans; Lewy Body Disease; Male; Neostriatum; Norepinephrine; Parkinson Disease; Radiopharmaceuticals; Shy-Drager Syndrome; Sympathetic Nervous System | 2012 |
18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Humans; Kinetics; Lewy Body Disease; Middle Aged; Tomography, Emission-Computed | 2000 |
Fluoro-DOPA and FDG positron emission tomography in a case of pathologically verified pure diffuse Lewy body disease.
Topics: Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Magnetic Resonance Imaging; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |